Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effectiveness of ChAdOx1 vaccine in older adults during SARS-CoV-2 Gamma variant circulation in São Paulo
Matt D. T. Hitchings, Otávio T. Ranzani, Murilo Dorión, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 71

Showing 26-50 of 71 citing articles:

Effectiveness of COVID-19 Vaccination on Reduction of Hospitalizations and Deaths in Elderly Patients in Rio Grande do Norte, Brazil
Ana Isabela L. Sales-Moioli, Leonardo J. Galvão-Lima, Talita K. B. Pinto, et al.
International Journal of Environmental Research and Public Health (2022) Vol. 19, Iss. 21, pp. 13902-13902
Open Access | Times Cited: 14
Estimated deaths averted in adults by COVID-19 vaccination in select Latin American and Caribbean Countries
Alexandra Savinkina, Daniel M. Weinberger, Cristiana M. Toscano, et al.
Open Forum Infectious Diseases (2024) Vol. 11, Iss. 10
Open Access | Times Cited: 2
Bias and negative values of COVID-19 vaccine effectiveness estimates from a test-negative design without controlling for prior SARS-CoV-2 infection
Ryan E. Wiegand, Bruce Fireman, Morgan Najdowski, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Antibody responses against SARS-CoV-2 variants induced by four different SARS-CoV-2 vaccines
Marit J. van Gils, A. H. Ayesha Lavell, Karlijn van der Straten, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 18
Change in covid-19 risk over time following vaccination with CoronaVac: test negative case-control study
Matt D. T. Hitchings, Otávio T. Ranzani, Margaret L. Lind, et al.
BMJ (2022), pp. e070102-e070102
Open Access | Times Cited: 13
Modelling optimal vaccination strategies against COVID-19 in a context of Gamma variant predominance in Brazil
Leonardo Souto Ferreira, Gabriel Berg de Almeida, Marcelo Eduardo Borges, et al.
Vaccine (2022) Vol. 40, Iss. 46, pp. 6616-6624
Open Access | Times Cited: 13
SARS-CoV-2 Delta variant induces enhanced pathology and inflammatory responses in K18-hACE2 mice
Katherine S. Lee, Ting Y. Wong, Brynnan P. Russ, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2022)
Open Access | Times Cited: 12
Vaccine effectiveness of ChAdOx1 nCoV-19 against COVID-19 in a socially vulnerable community in Rio de Janeiro, Brazil: a test-negative design study
Otávio T. Ranzani, Amanda De Araújo Batista Da Silva, Igor Tona Peres, et al.
Clinical Microbiology and Infection (2022) Vol. 28, Iss. 5, pp. 736.e1-736.e4
Open Access | Times Cited: 12
Association between primary or booster COVID-19 mRNA vaccination and Omicron lineage BA.1 SARS-CoV-2 infection in people with a prior SARS-CoV-2 infection: A test-negative case–control analysis
Margaret L. Lind, Alexander J. Robertson, Julio Silva, et al.
PLoS Medicine (2022) Vol. 19, Iss. 12, pp. e1004136-e1004136
Open Access | Times Cited: 12
Prior infections and effectiveness of SARS-CoV-2 vaccine in test-negative studies: A systematic review and meta-analysis
Tim K. Tsang, Sheena G. Sullivan, Xiaotong Huang, et al.
American Journal of Epidemiology (2024) Vol. 193, Iss. 12, pp. 1868-1881
Open Access | Times Cited: 2
Impact of CoronaVac on Covid-19 outcomes of elderly adults in a large and socially unequal Brazilian city: A target trial emulation study
Higor S. Monteiro, Antonio S. Lima Neto, Rebecca Kahn, et al.
Vaccine (2023) Vol. 41, Iss. 39, pp. 5742-5751
Open Access | Times Cited: 6
Test negative design for vaccine effectiveness estimation in the context of the COVID-19 pandemic: A systematic methodology review
Miceline Mésidor, Yan Liu, Denis Talbot, et al.
Vaccine (2023) Vol. 42, Iss. 5, pp. 995-1003
Closed Access | Times Cited: 6
Observational methods for COVID-19 vaccine effectiveness research: an empirical evaluation and target trial emulation
Martí Català, Edward Burn, Trishna Rathod‐Mistry, et al.
International Journal of Epidemiology (2023) Vol. 53, Iss. 1
Open Access | Times Cited: 5
A review of SARS-CoV-2 virology, vaccines, variants and their impact on the COVID-19 pandemic
Tetsuyuki Hirahata, Reeshan ul Quraish, Afraz ul Quraish, et al.
Reviews in Medical Microbiology (2024)
Closed Access | Times Cited: 1
Scope of SARS-CoV-2 variants, mutations, and vaccine technologies
Josephine Wambani, Patrick Okoth
The Egyptian Journal of Internal Medicine (2022) Vol. 34, Iss. 1
Open Access | Times Cited: 7
Heterologous immunity induced by 1st generation COVID-19 vaccines and its role in developing a pan-coronavirus vaccine
Raj S. Patel, Babita Agrawal
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Effectiveness, safety, and immunogenicity of half dose ChAdOx1 nCoV-19 COVID-19 Vaccine: Viana project
Valéria Valim, Olindo Assis Martins‐Filho, Maria da Penha Gomes Gouvea, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 7
Use of Whole-Genome Sequencing to Estimate the Contribution of Immune Evasion and Waning Immunity on Decreasing COVID-19 Vaccine Effectiveness
Margaret L. Lind, Richard Copin, Shane McCarthy, et al.
The Journal of Infectious Diseases (2022) Vol. 227, Iss. 5, pp. 663-674
Open Access | Times Cited: 7
Characteristics of replication and pathogenicity of SARS-CoV-2 Alpha and Delta isolates
Xiaoli Feng, Dandan Yu, Mi Zhang, et al.
Virologica Sinica (2022) Vol. 37, Iss. 6, pp. 804-812
Open Access | Times Cited: 6
Change in COVID-19 risk over time following vaccination with CoronaVac: A test-negative case-control study
Matt D. T. Hitchings, Otávio T. Ranzani, Margaret L. Lind, et al.
medRxiv (Cold Spring Harbor Laboratory) (2021)
Open Access | Times Cited: 8
Evidence of the Efficacy and the Effectiveness of First Generation COVID-19 Vaccines in Clinical Trials and Real-world Studies
Jingxin Li, Zhuopei Li, Yawen Zhu, et al.
Zoonoses (2022) Vol. 2, Iss. 1
Open Access | Times Cited: 5
Effectiveness of the Fiocruz recombinant ChadOx1-nCoV19 against variants of SARS-CoV-2 in the Municipality of Botucatu-SP
Sue Ann Costa Clemens, Carlos Magno Castelo Branco Fortaleza, Madeleine Crowe, et al.
Frontiers in Public Health (2022) Vol. 10
Open Access | Times Cited: 5
Assessing the effectiveness of COVID-19 vaccines in older people in Latin America
Alfonso J. Rodríguez‐Morales, Oscar H. Franco
The Lancet Healthy Longevity (2022) Vol. 3, Iss. 4, pp. e219-e220
Open Access | Times Cited: 4
SARS-CoV-2 vaccine challenge based on spike glycoprotein against several new variants
Rike Syahniar, Dayu Swasti Kharisma
Clinical and Experimental Vaccine Research (2022) Vol. 11, Iss. 2, pp. 173-173
Open Access | Times Cited: 4
Towards novel nano-based vaccine platforms for SARS-CoV-2 and its variants of concern: Advances, challenges and limitations
Sally A. Helmy, Rami Elmorsi, Soha A.M. Helmy, et al.
Journal of Drug Delivery Science and Technology (2022) Vol. 76, pp. 103762-103762
Open Access | Times Cited: 4

Scroll to top